News - Page 3 of 6 - Selux Diagnostics

In the News

Selux wins FDA breakthrough device designation for phenotyping platform

September 28, 2021

Selux Diagnostics Earns FDA Breakthrough Device Designation for Next Generation ‘Phenotyping’ (NGP) Platform for Positive Blood Culture and Sterile Body Fluid Samples

September 28, 2021

Health Tech: Aleksandar Vacic On How Selux Diagnostics’s Technology Can Make An Important Impact In Our Overall Wellness

August 19, 2021

BARDA grants additional funding for rapid antibiotic susceptibility test

June 14, 2021

Selux awarded $14.6 million from BARDA for rapid antimicrobial susceptibility testing

June 14, 2021

Selux Diagnostics receives additional $14.6M in BARDA funding after successfully completing first clinical trial

June 14, 2021

Selux Diagnostics Receives Additional $14.6 Million in BARDA Funding After Successfully Completing First Clinical Trial

June 9, 2021

Selux Diagnostics Nabs Additional $9.6M BARDA Payment for AST Technology

April 27, 2020

Selux Diagnostics Receives $9.6M For Development of Rapid Antimicrobial Testing

April 27, 2020